EGFR expression is associated with relapse in a melanoma cohort receiving adjuvant PD-1-based immunotherapy.

Publikation

EGFR expression is associated with relapse in a melanoma cohort receiving adjuvant PD-1-based immunotherapy.

Wissenschaftlicher Artikel/Review - 22.07.2023

Amaral Teresa, Pop Oltin Tiberiu, Chatziioannou Eftychia, Sinnberg Tobias, Niessner Heike, Zhao Jing Hua, Ring Sandra Stephanie, Jörger Markus, Schroeder Christopher, Armeanu-Ebinger Sorin, Cozzio Antonio, Leiter Ulrike, Thomas Ioannis, Jochum Wolfram, Garbe Claus, Forchhammer Stephan, Levesque Mitchell Paul, Mangana Joanna, Hölzel Michael, Dummer Reinhard, Schürch Christian M, Forschner Andrea, Flatz Lukas

Zitation

Amaral T, Pop O, Chatziioannou E, Sinnberg T, Niessner H, Zhao J, Ring S, Jörger M, Schroeder C, Armeanu-Ebinger S, Cozzio A, Leiter U, Thomas I, Jochum W, Garbe C, Forchhammer S, Levesque M, Mangana J, Hölzel M, Dummer R, Schürch C, Forschner A, Flatz L. EGFR expression is associated with relapse in a melanoma cohort receiving adjuvant PD-1-based immunotherapy. J Am Acad Dermatol 2023; 89:1072-1074.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

J Am Acad Dermatol 2023; 89

Veröffentlichungsdatum

22.07.2023

eISSN (Online)

1097-6787

Seiten

1072-1074